Chemagis Ltd.
Records under this name other than patents Chemagis Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,344,165 | Crystalline Rotigotine Base and Preparation Process Therefor Formerly held Lapsed on the fee record Ended Jan 1, 2025 · High confidence | Lapsed on the fee record | Ended Jan 1, 2025 | High confidence |
| US 6,649,796 | Process for the Preparation of Acetamide Derivatives Formerly held Term ended Term ended Apr 2, 2022 · High confidence | Term ended | Term ended Apr 2, 2022 | High confidence |
| US 7,659,398 | Imiquimod Production Process Formerly held Lapsed on the fee record Ended Feb 9, 2022 · High confidence | Lapsed on the fee record | Ended Feb 9, 2022 | High confidence |
| US 8,357,805 | (1R,1'R)-Atracurium Salts Separation Process Formerly held Lapsed on the fee record Ended Jan 22, 2021 · High confidence | Lapsed on the fee record | Ended Jan 22, 2021 | High confidence |
| US 8,357,807 | Novel Isoquinolinium Compounds Useful in the Preparation of Cisatracurium and Associated Intermediates Formerly held Lapsed on the fee record Ended Jan 22, 2021 · High confidence | Lapsed on the fee record | Ended Jan 22, 2021 | High confidence |
| US 8,354,537 | Novel R,r`-Atracurium Salts Formerly held Lapsed on the fee record Ended Jan 15, 2021 · High confidence | Lapsed on the fee record | Ended Jan 15, 2021 | High confidence |
| US 8,334,388 | Novel Palonosetron Salts and Processes for Preparation and Purification Thereof Formerly held Lapsed on the fee record Ended Dec 18, 2020 · High confidence | Lapsed on the fee record | Ended Dec 18, 2020 | High confidence |
| US 8,293,912 | Process for Producing Cisatracurium Compounds and Associated Intermediates Formerly held Lapsed on the fee record Ended Oct 23, 2020 · High confidence | Lapsed on the fee record | Ended Oct 23, 2020 | High confidence |
| US 6,100,400 | Process for the preparation of esters of [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]-ethoxy]acetic acid Formerly held Term ended Term ended Apr 15, 2019 · From the USPTO record | Term ended | Term ended Apr 15, 2019 | From the USPTO record |
| US 7,615,632 | Novel Crystalline Forms of Temozolomide Formerly held Lapsed on the fee record Ended Nov 10, 2017 · High confidence | Lapsed on the fee record | Ended Nov 10, 2017 | High confidence |